| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.38 | 0.03 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.43 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |